These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20737330)

  • 21. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
    AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
    Woodsong C; Alleman P
    AIDS Educ Prev; 2008 Apr; 20(2):171-87. PubMed ID: 18433322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use.
    Zubowicz EA; Oakes JK; Short MB; Perfect MM; Succop PS; Rosenthal SL
    J Womens Health (Larchmt); 2006 Oct; 15(8):952-61. PubMed ID: 17087619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will vaginal microbicides solve the HIV problem in Africa?
    Muula AS
    Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
    Abdool Karim Q; Abdool Karim SS; Frohlich JA; Grobler AC; Baxter C; Mansoor LE; Kharsany AB; Sibeko S; Mlisana KP; Omar Z; Gengiah TN; Maarschalk S; Arulappan N; Mlotshwa M; Morris L; Taylor D;
    Science; 2010 Sep; 329(5996):1168-74. PubMed ID: 20643915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa.
    Stadler JJ; Delany S; Mntambo M
    Soc Sci Med; 2008 Jan; 66(1):189-200. PubMed ID: 17904718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing.
    Braunstein S; van de Wijgert J
    J Womens Health (Larchmt); 2005 Jun; 14(5):424-33. PubMed ID: 15989415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers.
    Smith RJ; Bodine EN; Wilson DP; Blower SM
    AIDS; 2005 Mar; 19(4):413-21. PubMed ID: 15750395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda.
    Abaasa A; Crook A; Gafos M; Anywaine Z; Levin J; Wandiembe S; Nanoo A; Nunn A; McCormack S; Hayes R; Kamali A
    Trials; 2013 Feb; 14():33. PubMed ID: 23374729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meaning-making matters in product design: users' sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings.
    Rosen RK; van den Berg JJ; Vargas SE; Senocak N; Shaw JG; Buckheit RW; Smith KA; Guthrie KM
    Contraception; 2015 Dec; 92(6):596-601. PubMed ID: 26276246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
    Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD
    Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross cultural study of vaginal practices and sexuality: implications for sexual health.
    Martin Hilber A; Hull TH; Preston-Whyte E; Bagnol B; Smit J; Wacharasin C; Widyantoro N;
    Soc Sci Med; 2010 Feb; 70(3):392-400. PubMed ID: 19906477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young Women's use of a microbicide surrogate: the complex influence of relationship characteristics and perceived male partners' evaluations.
    Tanner AE; Fortenberry JD; Zimet GD; Reece M; Graham CA; Murray M
    Arch Sex Behav; 2010 Jun; 39(3):735-47. PubMed ID: 19224355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.
    Fan MD; Kramzer LF; Hillier SL; Chang JC; Meyn LA; Rohan LC
    Arch Sex Behav; 2017 May; 46(4):1111-1119. PubMed ID: 27571742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.
    Morrow KM; Fava JL; Rosen RK; Vargas S; Shaw JG; Kojic EM; Kiser PF; Friend DR; Katz DF;
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):78-91. PubMed ID: 24180360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
    Whitehead SJ; McLean C; Chaikummao S; Braunstein S; Utaivoravit W; van de Wijgert JH; Mock PA; Siraprapasiri T; Friedland BA; Kilmarx PH; Markowitz LE
    PLoS One; 2011; 6(9):e14831. PubMed ID: 21915249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.